The 20 references in paper T. Smirnova A., O. Borovikov V., E. Ponomarjova P., R. Khanferjan A., Т. Смирнова А., О. Боровиков В., Е. Пономарева П., Р. Ханферян А. (2014) “HELIСOBACTER PYLORI-АССОЦИИРОВАННАЯ ЯЗВЕННАЯ БОЛЕЗНЬ ЖЕЛУДКА: МИКРОБИОЛОГИЧЕСКАЯ И КЛИНИКО-ИММУНОЛОГИЧЕСКАЯ ЭФФЕКТИВНОСТЬ ТЕРАПИИ БЕЗ ИСПОЛЬЗОВАНИЯ АНТИБИОТИКОВ // HELIСOBACTER PYLORI-ASSOCIATED GASTRIC ULCER DISEASE: CLINICO-IMMUNOLOGI-CAL EFFECTIVENESS OF TREATMENT WITHOUT ANTIBIOTICS” / spz:neicon:mimmun:y:2005:i:4:p:397-404

1
Авакимян А.В. Эндоскопическое лечение язвенной болезни желудка.// Автореф. дисс. канд. мед. наук. – Краснодар, 1999.-24 с.
(check this in PDF content)
2
Ивашкин В.Т., Лапина Т.Л. Гастроэнтерология XXI века.// Русский медицинский журнал.- 2000; Т.8., No 17.- С. 697-703.
(check this in PDF content)
3
Назаров В.Е. Применение ронколейкина в лечении осложненных форм язвенной болезни луковицы двенадцатиперстной кишки // Материалы конференции: «Ронколейкин – новые аспекты клинического применения». 10 марта 1999.-СПб МАПО.С.-Петербург, 1999. - С.24-27.
(check this in PDF content)
4
Нестерова И.В., Колесникова Н.В., Чудилова Г.А. Методы оценки функциональной активности нейтрофильных гранулоцитов.- Краснодар, 1992, 20 с.
(check this in PDF content)
5
Шаробаро В.И., Богачев Р.С., Соловьев А.С. Определение субпопуляционного состава клеток иммунной системы больных язвой двенадцатиперстной кишки // Росс. журн. гастроэнтер. гепатол. колопроктол. - 1999. - Т.9.- No 6. – С. 49-52.
(check this in PDF content)
6
Blaser M. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease // J. Infect Dis.- 1999.-Vol.179, No6.No 15.-Р.23-30.
(check this in PDF content)
7
Endres N., Voland P., Neumayer N., Gerhard M., Wagner H., Prinz C. Incubation of peripheral blood lymphocytes with H.pylori leads to a G1 arrest: a mechanism for immune evasion // Current Opinion in Gastroenterology.- 2001.- Vol 17.- Suppl. 1.-P.129.
(check this in PDF content)
8
Fernando N., Holton J., Kengatharan K., Vaira D. Immune and cytokine response to Helicobacter antigens in control and TAP-1 mice // Current Opinion in Gastroenterology.- 2001.- Vol 17.- Suppl. 1.-P.131.
(check this in PDF content)
9
Hida N., Shimoyama T. Jr., Neville P., Dixon M.F., Axon A.T., Shimoyama T. Sr., Crabtree J.E. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cog status and peptic ulceration // J. Clin. Pathol.1999 Sep.- Vol.52, No 9.- P. 658-664.
(check this in PDF content)
10
Ihan A., Tepez B., Gubina M., Malovrh T., Kopitar A. Diminished interferon-gamma production in gastric mucosa T lymphocytes after H. pylori eradication in duodenal ulcer patients // Hepatogastroenterology.1999 May-Jun.- Vol.46, No27.- P. 1740-1745.
(check this in PDF content)
11
Imanishi J., Kita M., Yamaoka Y., Sawai N., Tanahashi T., Kodama T. Le role des cytokines dans la pathogenese des maladies gastro-intestinales associees a l’infection par Helicobacter pylori // C.R. Seances. So. Biol. Fil.- 1998.- Vol. 192, No5.- P.991-996.
(check this in PDF content)
12
Kuipers E.J. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. // Aliment. Pharmacol.Ther. – 1997.- No11(Suppl. 1)- P.71-88.
(check this in PDF content)
13
Luzza, F., T. Parrello, L. Sebkova, L. Pensabene, M. Imeneo, M. Mancuso, A.M. La Vecchia, G. Monteleone, P. Strisciuglio, and F. Pallone. 2001. Expression of proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. // Dig. Liver Dis.- Vol. 33.-Р.14-20.
(check this in PDF content)
14
Marshall B.J. Helicobacter pylori: the аetiologic agent for peptic ulcer // JAMA.-1995.-Vol.274.-P.1064-1066.
(check this in PDF content)
15
Mitchell H. M., Wiseman M., Ally R., Ahmed R., Segal I. The cytokine response to H. pylori is significantly different in symptomatic Sowetans compared with symptomatic Australians // Current Opinion in Gastroenterology.- 2001.- Vol 17.- Suppl 1.-P.17.
(check this in PDF content)
16
Queiroz D.M.M., Cinque S.M.S., Rocha G.A., Soares T.F., Cabral M.D.A., Nogueira A.M.F., CorreaOliveira R., Martins-Filho O.A. The role of Th1 and Th2 immune response in Helicobacter heilmannii (Hh)-associated infection // Current Opinion in Gastroenterology.- 2001,- Vol.-17.- Suppl 1.-P.62.
(check this in PDF content)
17
Rubin J., Lotze M. Acute gastric mucosal injury associated with the systemic administration of interleukin-4 // Surgery.- 1992. – Mar. - Vol.111, No3. – Р.274-280.
(check this in PDF content)
18
Sharma S.A., Tummuru M.K., Blaser M.J., Kerr,L.D. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells // J. Immunol.- 1998 Mar 1.- Vol. 160, No 5.-Р. 2401-2407.
(check this in PDF content)
19
Yamaoka Y., Kodama T., Kita M., Imanishi J., Kashima K., Graham D.Y. Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status // [published erratum appears in Gut 2000] Apr;46(4):584]. // Gut.1999 Dec.-Vol.4, No6.- P.804-811.
(check this in PDF content)
20
Wakatsuki Y., Shirai Y., Yamori M., Yoshida M., Watanabe T. A cellular immune response non-specific to H.pylori is still effective to prevent colonization in the stomach // Current Opinion in Gastroenterology.2001.- Vol 17.- Suppl 1.- P. 140.
(check this in PDF content)